版本:
中国

BRIEF-Aspen Pharmacare responds to South African Competition Commission investigation announcement

June 13 Aspen Pharmacare Holdings Ltd

* Noted announcement by South African Competition Commission

* Announcement that SACC will be investigating co for suspected abuse of dominance in respect of provision of cancer medication in South Africa

* ‍Committed to full and constructive engagement with Competition Commission in this investigation

* Not increased pricing of its products outside of this regulatory framework

* Clearly demonstrated its commitment to providing quality medicines affordably over many years; Supply of oncology products in question is no exception​​​​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐